Stock Events

Stock Events

Sonnet Biotherapeutics (SONN) Q1 2025 Earnings

13FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-6.12

-4.06

-1.99

0.07

Details

Expected EPS

-1.39

Actual EPS

-1.56

Surprise EPS

-0.17

Surprise Percent

+12.23%

Description

Sonnet Biotherapeutics (SONN) has reported earnings of -1.56 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.